Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430908 · ClinicalTrials.gov registry record
Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 166
- Enrollment target
NCT03430908: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03430908 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03430908 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
This is a prospective, single-arm cohort, observational study to determine the incidence of gastric tube malposition during blind insertion by an anesthesia provider.
Interventions
- OTHER Blind Gastric Tube Placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2019-06-17 |
What the finished NCT03430908 record still lists
NCT03430908 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blind Gastric Tube Placement is the first listed.
NCT03430908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03430908 about?
NCT03430908 is a clinical study titled "Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography". This is a prospective, single-arm cohort, observational study to determine the incidence of gastric tube malposition during blind insertion by an anesthesia provider.
What is the current status of trial NCT03430908?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2017-12-22. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT03430908?
The interventions under investigation include: Blind Gastric Tube Placement (OTHER).
Who is sponsoring clinical trial NCT03430908?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI